Conserved HBV and HCV sequences useful for gene silencing
Details for Australian Patent Application No. 2005319306 (hide)
International Classifications
Event Publications
19 July 2007 PCT application entered the National Phase
PCT publication WO2006/069064 Priority application(s): WO2006/069064
7 May 2009 Assignment before Grant
Nucleonics, Inc. The application has been assigned to Alnylam Pharmaceuticals, Inc.
12 January 2012 Application Accepted
Published as AU-B-2005319306
10 May 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser